Skip to main content

Advertisement

Log in

Effects of intravitreal bevacizumab treatment on proliferative retinopathy in a patient with cerebroretinal vasculopathy

  • Letter to the editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Richards A, van den Maagdenberg AM, Jen JC, Kavanagh D, Bertram P, Spitzer D et al (2007) C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet 39(9):1068–1070

    Article  CAS  PubMed  Google Scholar 

  2. Ophoff RA, DeYoung J, Service SK, Joosse M, Caffo NA, Sandkuijl LA et al (2001) Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-21.3. Am J Hum Genet Aug; 69(2):447–53

    Google Scholar 

  3. Andreoli CM, Miller JW (2007) Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 18(6):502–508

    Article  PubMed  Google Scholar 

  4. Moradian S, Ahmadieh H, Malihi M, Soheilian M, Dehghan MH, Azarmina M (2008) Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 246(12):1699–1705

    Article  CAS  PubMed  Google Scholar 

  5. Ciulla TA, Rosenfeld PJ (2009) Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration. Curr Opin Ophthalmol 20(3):158–165

    Article  PubMed  Google Scholar 

  6. Neubauer AS, Kook D, Haritoglou C, Priglinger SG, Kampik A, Ulbig MW, Ceklic L (2007) Bevacizumab and retinal ischemia. Ophthalmology 114(11):2096

    Article  PubMed  Google Scholar 

  7. Chung EJ, Roh MI, Kwon OW, Koh HJ (2008) Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema. Retina 28(7):957–963

    Article  PubMed  Google Scholar 

  8. Bonini-Filho M, Costa RA, Calucci D, Jorge R, Melo LA Jr, Scott IU (2009) Intravitreal bevacizumab for diabetic macular edema associated with severe capillary loss: one-year results of a pilot study. Am J Ophthalmol 147(6):1022–1030

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Stefanie Guthmann for excellent technical assistance.

Conflict of interest statement

The authors do not have any commercial interest in any of the materials and methods used in this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marcus Kernt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kernt, M., Gschwendtner, A., Neubauer, A.S. et al. Effects of intravitreal bevacizumab treatment on proliferative retinopathy in a patient with cerebroretinal vasculopathy. J Neurol 257, 1213–1214 (2010). https://doi.org/10.1007/s00415-010-5500-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-010-5500-0

Keywords

Navigation